119 related articles for article (PubMed ID: 16760450)
1. Burkitt's lymphoma--the message from microarrays.
Harris NL; Horning SJ
N Engl J Med; 2006 Jun; 354(23):2495-8. PubMed ID: 16760450
[No Abstract] [Full Text] [Related]
2. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of Burkitt's lymphoma.
Dave SS; Fu K; Wright GW; Lam LT; Kluin P; Boerma EJ; Greiner TC; Weisenburger DD; Rosenwald A; Ott G; Müller-Hermelink HK; Gascoyne RD; Delabie J; Rimsza LM; Braziel RM; Grogan TM; Campo E; Jaffe ES; Dave BJ; Sanger W; Bast M; Vose JM; Armitage JO; Connors JM; Smeland EB; Kvaloy S; Holte H; Fisher RI; Miller TP; Montserrat E; Wilson WH; Bahl M; Zhao H; Yang L; Powell J; Simon R; Chan WC; Staudt LM;
N Engl J Med; 2006 Jun; 354(23):2431-42. PubMed ID: 16760443
[TBL] [Abstract][Full Text] [Related]
4. Novel lymphoid neoplasms--the borderland between diffuse large B-cell lymphoma and Burkitt's lymphoma.
de Jong D
Haematologica; 2009 Jul; 94(7):894-6. PubMed ID: 19570750
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
6. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2009 Dec; 27(4):182-5. PubMed ID: 19670467
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics as an aid in the diagnosis of lymphomas.
Glassman AB; Hopwood V; Hayes KJ
Ann Clin Lab Sci; 2000 Jan; 30(1):72-4. PubMed ID: 10678586
[TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma: clinicopathologic features and differential diagnosis.
Ferry JA
Oncologist; 2006 Apr; 11(4):375-83. PubMed ID: 16614233
[TBL] [Abstract][Full Text] [Related]
9. Genomic diagnosis of Burkitt's lymphoma.
Lin BT
N Engl J Med; 2006 Sep; 355(10):1064; author reply 1064-5. PubMed ID: 16957156
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
12. Burkitt lymphoma versus diffuse large B-cell lymphoma.
Rosenwald A; Ott G
Ann Oncol; 2008 Jun; 19 Suppl 4():iv67-9. PubMed ID: 18519409
[No Abstract] [Full Text] [Related]
13. An aggressive case of Burkitt's lymphoma with t(8;14) and c-myc rearrangement transformed from CD5+ B-cell lymphoma.
Niwano H; Aoki S; Tsukada N; Toba K; Fuse I; Kishi K; Koike T; Takahashi H; Yamamori S; Shibata A; Aizawa Y
Ann Hematol; 1997; 75(5-6):221-5. PubMed ID: 9433379
[TBL] [Abstract][Full Text] [Related]
14. [Possible mechanisms of activation of the cellular myc gene in Burkitt's lymphoma].
Rupniewska ZM
Postepy Hig Med Dosw; 1986; 40(1):96-110. PubMed ID: 3532072
[No Abstract] [Full Text] [Related]
15. Chromosomal translocations and timing of malignant transformation in Burkitt's lymphoma.
Murphy SB; Harris A; Williams DL
N Engl J Med; 1984 Jul; 311(3):195-6. PubMed ID: 6610828
[No Abstract] [Full Text] [Related]
16. [Burkitt's and Burkitt-like lymphoma. Molecular definition and value of the World Health Organisation's diagnostic criteria].
Stein H; Hummel M
Pathologe; 2007 Feb; 28(1):41-5. PubMed ID: 17216514
[TBL] [Abstract][Full Text] [Related]
17. [Molecular diagnosis of malignant lymphomas].
Holte H; Kvaløy S; Delabie J; Trøen G; Smeland EB
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2352-6. PubMed ID: 19935935
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
19. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
20. t(8;14) Mature B-cell (Burkitt's) lymphoma/leukaemia with atypical morphology in a paediatric patient.
Chng WJ; Yeoh AE; Liu TC; Quah TC
Eur J Haematol; 2004 Nov; 73(5):386-7. PubMed ID: 15458521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
